Says Praetego News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Praetego Awarded $0 3M by National Eye Institute to Advance Novel Oral Drug for Diabetic Retinopathy

/PRNewswire/ (https://www.praetego.com/) Praetego Inc, a pharmaceutical company protecting patients from neurodegenerative diseases related to aging, is.

Praetego amadorinsRajag khalifahNational institute of diabetesPraetego incNational eye institutePrnewswire praetego incPenn state universityNational eyeNational instituteAlistair barberDiabetic retinopathyPenn stateAdvanced glycation end productsChief scientific officerPrincipal investigatorSays praetego

Praetego Inc Awarded New NIH Funding to Investigate Novel Small Molecule Drug Candidates for Neurodegeneration and Alzheimer s Disease

Praetego Inc Awarded New NIH Funding to Investigate Novel Small Molecule Drug Candidates for Neurodegeneration and Alzheimer s Disease
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesRajag khalifahCorinne jolivaltNational institute of diabetesSchool of medicinePraetego incNational institutes of healthUniversity of california at san diegoNational institute of agingNational institutesNational instituteKidney diseasesAdvanced glycation end productsDiabetic peripheral neuropathySan diegoProfessor corinne jolivalt